Patents by Inventor John L. Lewis, Jr.

John L. Lewis, Jr. has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 4863854
    Abstract: Three new monoclonal antibodies, MU78, MT334, and MQ49, and the hybridoma cell lines producing these, are disclosed. The antibodies specifically bind to mucin-like antigens with distribution over various carcinomas.
    Type: Grant
    Filed: August 12, 1985
    Date of Patent: September 5, 1989
    Assignee: Sloan-Kettering Institute for Cancer Research
    Inventors: M. Jules Mattes, John L. Lewis, Jr., Lloyd J. Old, Kenneth O. Floyd, Katherine Look
  • Patent number: 4851332
    Abstract: Monoclonal antibodies to specific cell surface antigens of human choriocarcinoma, teratocarcinoma, and normal trophoblasts are disclosed. Additionally, panels of monoclonal antibodies which may be used in phenotyping cell and tissue samples are disclosed as well.
    Type: Grant
    Filed: April 1, 1985
    Date of Patent: July 25, 1989
    Assignee: Sloan-Kettering Institute for Cancer Research
    Inventors: Wolfgang J. Rettig, Carlos Cordon-Cardo, John P. Koulos, John L. Lewis, Jr., Herbert F. Oettgen, Lloyd J. Old
  • Patent number: 4666845
    Abstract: Mouse monoclonal antibodies to several cell antigens of human ovarian, cervical and endometrial carcinomas have been produced and characterized. The distribution of the antigens was determined by mixed hemagglutination assays on 153 normal and malignant cell cultures of various types, and by immunoperoxidase staining of frozen sections of 27 normal adult and 24 fetal tissues. five monoclonal antibodies representative of five classes of mAb raised to restricted ovarian, cervical and endometrial cells were tested extensively producing mAb reactive with cancer but not normal cells. One such mAb, MF116 was readily detected in the spent culture medium of metabolically radiolabeled cells. These antibodies, reacting with relatively restricted cell surface antigens, are useful in the analysis of epithelial cell differentiation, in cancer diagnosis and therapy and in tissue typing of normal or abnormal cells.
    Type: Grant
    Filed: December 16, 1983
    Date of Patent: May 19, 1987
    Assignee: Sloan-Kettering Institute
    Inventors: M. Jules Mattes, John L. Lewis, Jr., Kenneth O. Lloyd, Lloyd J. Old, Carlos Cordon-Cardo